Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | Cardiovascular Diabetology

Figure 2

From: YKL-40 - an emerging biomarker in cardiovascular disease and diabetes

Figure 2

Mean (95% confidence intervals) of ln-transformed YKL-40. Equivalent YKL-40 data (median (interquartile range)), are for macroalbuminuria/diabetic nephropathy (U-albumin > 300 mg/24 h), YKL-40 = 117 (68-215) ng/ml; persistent microalbuminuria (U-albumin 30-300 mg/24 h), YKL-40 = 74 (45-160) ng/ml; normoalbuminuria (U-albumin < 30 mg/24 h), YKL-40 = 53 (32-105) ng/ml; control group, YKL-40 = 37 (29-52) ng/ml. P < 0.001 for all comparisons. Groups were matched according to gender and duration of diabetes (> 30 years).

Back to article page